SUSAN SMITH: Open Payments
NPI 1154441251 · PONCHATOULA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,145 in 97 payments from 18 companies in 2025. Trend: 2023 $1,596 · 2024 $1,639 · 2025 $2,145
Food & beverage: $1,943Education: $202
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $528 |
| ABBVIE INC. | 41 | $499 |
| Regeneron Healthcare Solutions, Inc. | 9 | $297 |
| UCB, Inc. | 13 | $195 |
| Lilly USA, LLC | 2 | $130 |
| PFIZER INC. | 5 | $107 |
| Amgen Inc. | 4 | $71 |
| LNHC, Inc | 2 | $48 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| LEO Pharma Inc. | 2 | $41 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, RINVOQ, EBGLYSS, CIBINQO, OTEZLA.
Industry payments across LA — which companies pay providers there.
